DOCSLIB.ORG

National Maternal and Child Health (MCH) Epidemiology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
National Maternal and Child Health (MCH) Epidemiology National Maternal and Child Health (MCH) Epidemiology AwardsAwards Presented by the Coalition for Excellence in MCH Epidemiology 2018 CityMatCH Leadership and MCH Epidemiology Conference Maternal and Child HealthThe systematic collection, Epidemiology analysis and interpretation ofis... population- based and program-speci c health and related data in order to assess the distribution and determinants of the health status and needs of the maternal child population for the purpose of planning, implementing, and assessing e ective, science-based strategies and promoting policy development. PurposeTo recognize individuals, of teams, the institutions Awards and leaders of institutions for making signi cant contributions to one or more aspects of this de nition with the aim of improving the health of women, children and families by: • Advancing public health knowledge through epidemiology and applied research, • Improving public health practice through e ective use of data and epidemiology and training in the eld, and • Enhancing the political will to support practice and advance knowledge through e ective use of data, epidemiology and applied research. The Coalition for Excellence in MH Epidemiology The National Maternal and Child Health (MCH) Epidemiology Awards • Centers for Disease Control and Prevention (CDC), Division of recognize individuals, teams, institutions, and leaders for making Reproductive Health signi cant contributions to improve the health of women, children, • CityMatCH and families by: • Council of State and Territorial Epidemiologists (CSTE) • Advancing public health knowledge through MCH epidemiology and applied research; • Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau • Improving public health practice through the e ective use of MCH data and epidemiology; • Maternal and Child Health Journal • Strengthening MCH public health practice through excellence in • National Association of County and City Health O cials (NACCHO) teaching and training in the use of data, epidemiologic methods • National Association for Public Health Statistics and Information and applied research; and Systems (NAPHSIS) • Providing leadership to enhance the political will to advance • National Birth Defects Prevention Network (NBDPN) public health knowledge and practice and the e ective use of • National March of Dimes Foundation MCH data, epidemiology, and applied research. • National Institutes of Health, Eunice Kennedy Shriver National No one organization represents MCH Epidemiology as a profession Institute of Child Health and Human Development (NICHD) from both an academic and practice perspective. MCH Epidemiology, • Society for Pediatric and Perinatal Epidemiologic Research (SPER) however, is a major contributor and participant in many health organizations and professional groups. To better recognize the For 2018, the Coalition recognizes six individuals or organizations eld as a whole and to promote excellence in MCH Epidemiology, for their excellent contribution to Maternal and Child Health in ve 16 national health organizations have formed the Coalition for categories: Lifetime Achievement, E ective Practice, Early Career Excellence in MCH Epidemiology to sponsor the National MCH Professional Achievement, and Advancing Knowledge. Epidemiology Awards. • American Academy of Pediatrics (AAP), Epidemiology Section • American Public Health Association (APHA), Maternal and Child Health Section • Association of Maternal and Child Health Programs (AMCHP) • Association of Schools and Programs of Public Health (ASPPH), Maternal and Child Health Council • Association of Teachers of Maternal and Child Health (ATMCH) Event Emcee Charlan Kroelinger, PhD Dr. Charlan Kroelinger emcees today’s event on behalf of the Coalition for Excellence in MCH Epidemiology. Dr. Kroelinger is the lead for the Maternal and Child Health (MCH) Epidemiology Program housed in the Division of Reproductive Health at the Centers for Disease Control and Prevention. The goal of the program is to provide direct assistance to states, territories, localities, and tribes on issues related to pregnancy, infant, and women’s health. This direct assistance is provided by senior MCH epidemiologists placed in agencies, health departments, and epidemiology centers to build capacity and increase infrastructure in the development of MCH programs and policies. Before taking leadership of the program, Dr. Kroelinger was the senior scientist for the program ensuring production of high quality science, and prior to that, was assigned in the eld to the Delaware Division of Public Health as the State Maternal and Child Health Epidemiologist. In Delaware, she worked as a Director of Science with the state health department to implement the Governor’s Infant Mortality Initiative to decrease the rate of infant deaths in the state. She has spent her career working with mothers and infants, and is dedicated to improving the health of women, children, and families. Dr. Kroelinger received her doctorate in epidemiology and biostatistics from the University of South Florida, and her Master’s Degree in applied medical anthropology from The University of Alabama. Questions about nominations should be sent to: Dr. Charlan D. Kroelinger Chair, National MCH Epi Awards Committee MCH EPI Team Lead Division of Reproductive Health Centers for Disease Control and Prevention 4770 Buford Hwy. NE. MS F-74 Atlanta, GA 30341-3717 Phone: 770-488-6545 | Fax: 770-488-6291 [email protected] Zena Stein and Mervyn Susser Award for Lifetime Achievement The purpose of this award is to recognize an internationally or of childhood morbidities, and, more importantly, that the risk factors nationally known expert or team of experts who have contributed for this morbidity are similar to those for term children emphasizing the broadly and substantially to the advancement of the eld of importance of socio-economic status and parental health. More recently, she has critiqued the reliance on standardized and restricted measures of MCH epidemiology throughout their career, and whose work has neurodevelopment as the major indicators of outcomes and emphasized signi cant and lasting impact. This award is considered to be a the importance of functional outcomes, to predict what children can capstone award; hence its recipient(s) should be at or near the achieve regardless of IQ scores. end of their career. The proposed lifetime achievement in MCH Dr. McCormick believes that describing the outcomes and risk factors epidemiology award will be given only when deemed appropriate, is insu cient unless accompanied by the identi cation of evidence- and is not expected to be awarded annually. No more than one based interventions critical to improving outcomes. Thus, in addition to lifetime achievement award will be given in any calendar year. her scienti c work, Dr. McCormick has served as the Research Steering Committee Chair for the Infant Health and Development Program, evaluating the e ectiveness of early education for low birth weight and premature infants as the principal investigator of the 18-year follow-up. Based on her expertise, Dr. McCormick has been asked to serve on several 2018 Recipient committees and has had a direct and lasting impact on children’s health. Marie Clare McCormick, MD, ScD Most notably, she has been active in a number of Institute of Medicine/ National Academy of Medicine panels. Her work on vaccine safety also has Dr. Marie McCormick has actively led to her being on the National Vaccine Advisory Committee where she promoted and substantially improved chaired the Working Group overseeing the safety of the epidemic H1N1 maternal and child health through in uenza vaccine in 2009. She has played signi cant leadership roles in her research, policy development and academic societies, especially the Academic Pediatric Association for which training of young Maternal and Child she was the Chair of the Communications and Research Committees and Health epidemiologists. After nearly Senior Associate Editor of the association’s journal. In that capacity, she 40 years as a scientist and a scholar, developed an annual report on the health care use and expenditures of she will retire as the rst Sumner and American children, both overall and for various conditions, in collaboration Esther Feldberg Professor of Maternal with Lisa Simpson and the Agency for HealthCare Research and Quality. and Child Health in September 2018. For this work, Dr. McCormick has received numerous awards, including the Her research has two main foci: David Rall Medal for exemplary service to the Institute of Medicine, and two elucidating the outcomes of high- life-time research achievement awards. Perhaps one of her most telling risk, especially premature infants and the evaluation of programs designed awards, however, is the A. Cli ord Barger Excellence in Mentoring Award to reduce infant mortality and improve the outcomes of vulnerable infants. from the Harvard Medical School. This award captures her impressive An early summary of the existing literature in the New England Journal of legacy in MCH Epidemiology through her teaching and mentoring of young Medicine signaled what work she was to accomplish. She was among the investigators and public health professionals, all of whom have gone on rst to report on the increased risk of rehospitalization after discharge from to notable careers themselves. Dr. McCormick supports her mentees with the NICU, the lower risk of injuries and the impact on
Load more

Recommended publications
  • Christine Stencel, Media Relations Officer Chris Dobbins, Media
    Date: May 18, 2004 Contacts: Christine Stencel, Media Relations Officer Chris Dobbins, Media Relations Assistant Office of News and Public Information 202-334-2138; e-mail <[email protected]> FOR IMMEDIATE RELEASE MMR Vaccine and Thimerosal-Containing Vaccines Are Not Associated With Autism, IOM Report Says WASHINGTON -- Based on a thorough review of clinical and epidemiological studies, neither the mercury-based vaccine preservative thimerosal nor the measles-mumps-rubella (MMR) vaccine are associated with autism, says a new report from the Institute of Medicine of the National Academies. Furthermore, the hypotheses regarding how the MMR vaccine and thimerosal could trigger autism lack supporting evidence and are theoretical only. Further research to find the cause of autism should be directed toward other lines of inquiry that are supported by current knowledge and evidence and offer more promise for providing an answer, said the committee that wrote the report. "The overwhelming evidence from several well-designed studies indicates that childhood vaccines are not associated with autism," said committee chair Marie McCormick, Sumner and Esther Feldberg Professor of Maternal and Child Health, Harvard School of Public Health, Boston. "We strongly support ongoing research to discover the cause or causes of this devastating disorder. Resources would be used most effectively if they were directed toward those avenues of inquiry that offer the greatest promise for answers. Without supporting evidence, the vaccine hypothesis does not hold such promise." The report updates two earlier IOM reports, published in 2001, on possible links between autism and the MMR vaccine and thimerosal. At that time, the committee determined that the evidence did not show an association between the MMR vaccine and autism, but there was not enough evidence to determine whether thimerosal was associated with neurodevelopmental disorders such as autism.
    [Show full text]
  • Stephen W. Patrick, MD, MPH, MS, FAAP
    Stephen W. Patrick, MD, MPH, MS, FAAP Director, Vanderbilt Center for Child Health Policy Associate Professor of Pediatrics and Health Policy, Division of Neonatology Vanderbilt University School of Medicine 2525 West End Avenue, Suite 1200 Nashville, TN 37203 (Phone) 615-875-5891 (Fax) 615-343-1763 [email protected] EDUCATION 8/1998-5/2002 BS, Microbiology and Cell Science, Highest Honors University of Florida, Gainesville, FL 5/2002-5/2007 MD Florida State University College of Medicine, Tallahassee, FL 9/2005-11/2007 MPH, Health Policy and Management Harvard University School of Public Health, Boston, MA 07/2010-12/2011 MS, Health and Health Care Research University of Michigan, Ann Arbor, MI POST-DOCTORAL TRAINING 6/2007-6/2010 House Officer Department of Pediatrics and Communicable Diseases University of Michigan Health System, Ann Arbor, MI 7/2010-6/2012 Robert Wood Johnson Foundation Clinical Scholar University of Michigan Health System, Ann Arbor, MI 7/2010-6/2013 Neonatal-Perinatal Medicine Fellow Department of Pediatrics and Communicable Diseases University of Michigan Health System, Ann Arbor, MI Certifications 2005-present Pediatric Advanced Life Support 2005-present Basic Life Support/Advanced Cardiac Life Support 2007-present Neonatal Resuscitation Program 2013-present Neonatal Resuscitation Program Instructor License 5/2010-2014 Board of Medicine, State of Michigan #4301090178 5/2013-present Board of Medicine, State of Tennessee #50051 Board Certification 10/2011-present American Board of Pediatrics – Pediatrics
    [Show full text]
  • Section on Neonatal-Perinatal Medicine
    SECTION ON NEONATAL-PERINATAL MEDICINE NEWSLETTER - Winter 2020 www.aap.org/perinatal MOCA-Peds for Neonatal-Perinatal Perinatal News “At a Glance” Medicine Mary Nock, MD, FAAP, Editor Vivian Thorne, Production Heather French MD, MSEd Beginning in 2020, the American Board of Pediatrics MOCA-Peds for Neonatal-Perinatal Medicine . 1 (ABP) is launching an alternative to fulfill the medical View From the Chair: An Unorthodox Column . 2 knowledge requirement (Part 3) of the Maintenance of Certification (MOC) program in Neonatal Perinatal National Association of Neonatal Nurses (NANN) and Medicine (NPM). Previously, the NPM recertification National Association of Neonatal Nurse Practitioners examination served as the only option to fulfill the (NANNP) Report . 3 Part 3 requirement. Maintenance of Certification Getting to Know… Assessment for Pediatrics, or MOCA-Peds, is an James Barry MD, District VIII Representative . 4 alternative to taking the NPM recertification ONTPD Update . 5 examination. MOCA-Peds is NOT a replacement for the initial certification examination for NPM. MidCaN Rising Star… Trent Tipple MD, FAAP . 6 MOCA-Peds is a web-based assessment program Women in Neonatology . 7 for pediatricians using multiple choice questions TECaN Update . 8 (MCQ) that are clinically relevant. Instead of a single exam day, pediatricians can demonstrate medical Highlights from the SoNPM Program at the 2019 NCE . 9 knowledge and clinical judgment in a flexible and 2020 AAP NCE SoNPM Program in San Diego, CA . 10 dynamic model that emphasizes continuous learning that is better aligned with the changing environment SoNPM Task Force for Neonatal Perinatal of clinical practice. MOCA-Peds uses an online Therapeutic Development .
    [Show full text]
  • Health Effects of Marijuana and Cannabis-Derived Products
    Contact Us | Current Operating Status Home About Us Organization Events & Activities Resources Jan. 14, 2017 Back | Home Media Contacts News Release Archive Media Tipsheet Multimedia Jan. 12, 2017 Presidents' Corner Communications Awards FOR IMMEDIATE RELEASE FAQ Nearly 100 Conclusions on the Health Effects of Marijuana and Cannabis-Derived Products Presented in New Report; One of the Most Comprehensive Studies of Recent Research on Health Effects of Recreational and Therapeutic Use of Cannabis and Cannabis-Derived Products WASHINGTON – A new report from the National Academies of Sciences, Engineering, and Medicine offers a rigorous review of scientific research published since 1999 about what is known about the health impacts of cannabis and cannabis- derived products – such as marijuana and active chemical compounds known as cannabinoids – ranging from their therapeutic effects to their risks for causing certain cancers, diseases, mental health disorders, and injuries. The committee that carried out the study and wrote the report considered more than 10,000 scientific abstracts to reach its nearly 100 conclusions. The committee also proposed ways to expand and improve the quality of cannabis research efforts, enhance data collection efforts to support the advancement of research, and address the current barriers to cannabis research. “For years the landscape of marijuana use has been rapidly shifting as more and more states are legalizing cannabis for the treatment of medical conditions and recreational use,” said Marie McCormick, chair of the committee; the Sumner and Esther Feldberg Professor of Maternal and Child Health, department of social and behavioral sciences, Harvard T.H. Chan School of Public Health; and professor of pediatrics, Harvard Medical School, Cambridge, Mass.
    [Show full text]
  • Effect of Healthy Start on Infant Mortality and Birth Outcomes
    Contract No.: 240-93-0050 MPR Reference No.: 8166-111 EFFECT OF HEALTHY START ON INFANT MORTALITY AND BIRTH OUTCOMES July 2000 Lorenzo Moreno Barbara Devaney Dexter Chu Melissa Seeley Submitted to: Submitted by: Health Resources and Services Administration Mathematica Policy Research, Inc. Parklawn Building, Room 14-36 P.O. Box 2393 5600 Fishers Lane Princeton, NJ 08543-2393 Rockville, Maryland 20857 (609) 799-3535 Project Officer: Project Director: Karen T. Raykovich Embry Howell ACKNOWLEDGMENTS The authors thank the following federal and state entities for providing the vital records for this report: C Alabama Department of Public Health C Baltimore City Department of Health C California Department of Health Services C District of Columbia State Center for Health Statistics C Illinois Department of Public Health C Indian Health Service (IHS), Public Health Service, U.S. Department of Health and Human Services C Indiana State Department of Health C Louisiana Department of Health and Hospitals C Massachusetts Department of Health and Hospitals C Michigan Department of Health C New York City Department of Health C Ohio Department of Health C Pennsylvania Department of Health C South Carolina Department of Health and Environmental Control The authors also thank Patricia Ciaccio, Roy Grisham, and Walter Brower of Mathematica Policy Research, Inc. for editing the report; and Cindy McClure, Marjorie Mitchell, and Jane Nelson of Mathematica Policy Research for producing it. iii CONTENTS Chapter Page EXECUTIVE SUMMARY ......................................... xi I INTRODUCTION .................................................1 A. PROGRAM BACKGROUND ....................................2 B. THE NATIONAL HEALTHY START EVALUATION ................5 II STUDY METHODOLOGY .........................................7 A. SELECTION OF COMPARISON AREAS ..........................7 1. Selection Process ............................................9 2.
    [Show full text]
  • Advisory Committee on the Maternal, Infant and Early Childhood Home Visiting Program’S Evaluation
    Advisory Committee on the Maternal, Infant and Early Childhood Home Visiting Program’s Evaluation Roster May 2011 Hortensia Amaro, Ph.D. Professor of Health Sciences and Counseling Psychology Director of the Institute on Urban Health Research, Bouve College of Health Sciences, Northeastern University 360 Huntington Avenue 310 International Village Boston, MA 02115-5000 Phone: 617-373-7601 Fax: 617-373-7309 [email protected] Mark Appelbaum, Ph.D. Professor, Department of Psychology -0109 University of California, San Diego LaJolla, CA 92093-0109 Phone: 858-534-7959 Fax: 858-534-7190 [email protected] Maureen Black, Ph.D. Professor of Pediatrics Division of Growth and Nutrition Department of Pediatrics University of Maryland School of Medicine 737 W. Lombard Street, Room 161 Baltimore, Maryland 21201 [email protected] Robert H. Bradley, Ph.D., M.A. Professor School of Social & Family Dynamics Arizona State University 951 S. Cady Mall Tempe, AZ 85287 Phone: 480-965-6439 Fax: 480-965-8674 [email protected] MIECHVPE Page 1 Advisory Committee on the Maternal, Infant and Early Childhood Home Visiting Program’s Evaluation C. Hendricks Brown, Ph.D., M.A. Professor and Director Prevention Science and Methodology Group Center for Family Studies Department of Epidemiology and Public Health University of Miami Miller School of Medicine 1425 N.W. 10th Avenue Miami, FL 33136 Phone: 305-243-2529 [email protected] Greg Duncan, Ph.D. Professor of Education University of California, Irvine 2001 Berkeley Place Irvine, CA 92697-5500 (949)824-7831 voice (949)824-2965 fax [email protected] Catherine Gallagher, Ph.D.
    [Show full text]
  • Autism--Why the Increased Rates? a One-Year Update. Hearings
    DOCUMENT RESUME ED 467 484 EC 309 127 TITLE Autism--Why the Increased Rates? A One-Year Update. Hearings before the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, First Session, April 25 and 26, 2001. INSTITUTION Congress of the U.S., Washington, DC. House Committee on Government Reform. REPORT NO House-Hrg-107-29 PUB DATE 2001-04-00 NOTE 397p. AVAILABLE FROM Superintendent of Documents, U.S. Government Printing Office, Mail Stop: SSOP, Washington, DC 20402-0001. Tel: 202 -512- 1800; Tel: 866-512-1800 (Toll Free); Fax: 202-512-2250. For full text: http://www.gpo.gov/congress/house. PUB TYPE Legal/Legislative/Regulatory Materials (090) EDRS PRICE EDRS Price MFO1 /PC16 Plus Postage. DESCRIPTORS *Autism; Comparative Analysis; Data Analysis; Epidemiology; Etiology; Hearings; *Immunization Programs; *Incidence; *Symptoms (Individual Disorders); *Trend Analysis IDENTIFIERS Congress 107th ABSTRACT These hearings before the House of Representatives Committee on Government Reform address possible reasons for the apparently rapid increase in the incidence of autism. An introduction by the Committee Chairman, Dan Burton, provides background information and suggests a possible linkage between autism and the mumps-measles-rubella vaccine, specifically the possibility of mercury contamination. Text is included of statements from representatives of the following: the Committee on Immunization Safety, Institute of Medicine; National Academy of Sciences; Indiana University School of Medicine; McGill University; MIND Institute, University of California, Davis; National Institute of Child Health and Human Development; Office of Vaccine Research and Review, Food and Drug Administration; Office of Vital Statistics and Epidemiology; and the Center on Birth Defects and Developmental Disabilities.
    [Show full text]
  • ED 336 904 AUTHOR Berendes, Heinz W., Ed.; and Others TITLE Advances in the Prevention of Low Birthweight. Proceedings from an I
    ED 336 904 EC 300 636 AUTHOR Berendes, Heinz W., Ed.; And Others TITLE Advances in the Prevention of Low Birthweight. Proceedings from an International Symposium (Cape Cod, Massachusetts, May 8-11, 1988). INSTITUTION National Center for Education in Maternal and Child Health, Waseington, DC. SPONS AGENCY Health Resources and Services Administration (DHHS/PHS), Rockville, MD. Bureau of Maternal and Child Health and Resources Development.; National Inst. of Child Health and Human Levelopment (NTH), Bethesda, Md. PUB DATE 91 CONTRACT MCU-117007 NOTE 247p. AVAILABLE FROMNational Maternal and Child Health Clearinghouse (NMCHC), 38th and R Streets, N.W., Washington, DC 20037 (single copies free). PUB TYPE Collected Works - Conference Proceedings (021) EDRS PRICE MFC1/PC10 Plus Postage. DESCRIPTORS *Birth Weight; *Congenital Impairments; Etiology; Infants; Medical Researcn; Neonates; Nutrition; Perinatal Influences; Pregnancy; *Premature Infants; *Prenatal Influences; *Prevention; *Preventive Medicine; Smoking; Social Support Groups; Stress Variables ABSTRACT This proceedings document contains papers addressing trends, determinants, and interventions in preventing low birthweight. Papers have the following titles and authors: "Trends in Rates of Low Birthweight in the United States" (Mary McCormick); "Evolution of the Preterm Birth Rate in France" (Gerard Breart); "The Etiology and Prevention of Low Birthweight: Current Knowledge and Priorities for Future Research" (Michael Yramer); "Support and Stress during Pregnancy: What Do They Tell Us about
    [Show full text]
  • 18 Infant Health and Development Program
    18 Infant Health and Development Program Douglas J. Besharov Peter Germanis Caeli A. Higney and Douglas M. Call September 2011 Maryland School of Public Policy Welfare Reform Academy www.welfareacademy.org Part of a forthcoming volume Assessments of Twenty-Six Early Childhood Evaluations by Douglas J. Besharov, Peter Germans, Caeli A. Higney, and Douglas M. Call Note: This report is open to public comments, subject to review by the forum moderator. To leave a comment, please send an email to [email protected] or fill out the comment form at http://www.welfareacademy.org/pubs/early_education/chapter18.html. 18 Infant Health and Development Program The Infant Health and Development Program (IHDP), carried out in eight medical centers from 1985 to 1988, was designed as a test of providing comprehensive early intervention services to low birth weight (LBW) children. These children were targeted because of their heightened risk of developing learning disabilities, experiencing academic problems, and exhibiting behavior problems. A national IHDP office guided the efforts of eight sites associated with medical schools.1 Ruth T. Gross, Professor of Pediatrics at Stanford University, Jeanne Brooks-Gunn, Virginia and Leonard Marx Professor of Child Development and Education at Teachers College, Columbia University, Cecelia M. McCarton, Clinical Professor of Pediatrics, Albert Einstein College of Medicine, and Marie C. McCormick, professor and chair, Department of Maternal and Child Health, Harvard School of Public Health, headed teams composed of dozens of other independent analysts (the “IHDP evaluation team”) in evaluating the IHDP, using random assignment and following the infants through age eighteen. Program children exhibited early IQ gains that dissipated by age eighteen.
    [Show full text]
  • Variation Among Neonatal Intensive Care Units in Narcotic Administration
    ARTICLE Variation Among Neonatal Intensive Care Units in Narcotic Administration Doron J. Kahn; Douglas K. Richardson, MD, MBA; James E. Gray, MD, MS; Francis Bednarek, MD; Lewis P. Rubin, MD; Bhavesh Shah, MD; Ivan D. Frantz III, MD; DeWayne M. Pursley, MD Objectives: To compare rates of narcotic administra- and 14, 2%), and NICU. We restricted analyses to the 1018 tion for medically treated neonates in different neonatal neonates who received mechanical ventilation on day 1. intensive care units (NICUs) and to compare treated and Logistic regression, adjusting for birth weight and SNAP, untreated neonates to assess whether narcotics pro- confirmed a 28.6-fold variation in narcotic administra- vided advantages or disadvantages for short-term out- tion (odds ratios, 4.1-28.6 vs NICU A). Several short-term comes, such as cardiovascular stability (ie, blood pres- outcomes also were associated with narcotic use, includ- sure and heart rate), hyperbilirubinemia, duration of ing more than 33 g of fluid retention on day 3 and a higher respiratory support, growth, and the incidence of intra- direct bilirubin level (6.8 µmol/L higher [0.4 mg/dL higher], ventricular hemorrhage. P = .03). There were no differences in weight gain at 14 and 28 days or mechanical ventilatory support on days 14 and Study Design: The medical charts of neonates weighing 28. Narcotic use was not associated with differences in worst less than 1500 g, admitted to 6 NICUs (A-F), were ab- blood pressure or heart rate or with increased length of hos- stracted. Neonates who had a chest tube or who had un- pital stay.
    [Show full text]
  • Stephen W. Patrick, MD, MPH, MS, FAAP
    Stephen W. Patrick, MD, MPH, MS, FAAP Director, Vanderbilt Center for Child Health Policy Assistant Professor of Pediatrics and Health Policy, Division of Neonatology Vanderbilt University School of Medicine 2525 West End Avenue, Suite 1200 Nashville, TN 37203 (Phone) 615-875-5891 (Fax) 615-343-1763 [email protected] EDUCATION 8/1998-5/2002 BS, Microbiology and Cell Science, Highest Honors University of Florida, Gainesville, FL 5/2002-5/2007 MD Florida State University College of Medicine, Tallahassee, FL 9/2005-11/2007 MPH, Health Policy and Management Harvard University School of Public Health, Boston, MA 07/2010-12/2011 MS, Health and Health Care Research University of Michigan, Ann Arbor, MI POST-DOCTORAL TRAINING 6/2007-6/2010 House Officer Department of Pediatrics and Communicable Diseases University of Michigan Health System, Ann Arbor, MI 7/2010-6/2012 Robert Wood Johnson Foundation Clinical Scholar University of Michigan Health System, Ann Arbor, MI 7/2010-6/2013 Neonatal-Perinatal Medicine Fellow Department of Pediatrics and Communicable Diseases University of Michigan Health System, Ann Arbor, MI Certifications 2005-present Pediatric Advanced Life Support 2005-present Basic Life Support/Advanced Cardiac Life Support 2007-present Neonatal Resuscitation Program 2013-present Neonatal Resuscitation Program Instructor License 5/2010-present Board of Medicine, State of Michigan #4301090178 5/2013-present Board of Medicine, State of Tennessee #50051 Board Certification 10/2011-present American Board of Pediatrics – Pediatrics
    [Show full text]
  • The Health Effects of Cannabis and Cannabinoids
    5.7 K 255 ~'~ ~~ ~Jc~t.~fzcrt ,e~t~~~~~t~~~ ~~~ Jan. 12, 2017 FOR IMMEDIATE RELEASE Nearly 100 Conclusions on the Health Effects of Marijuana and Cannabis-Derived Products Presented in New Report; One of the Most Comprehensive Studies of Recent Research on Health Effects of Recreational and Therapeutic Use of Cannabis and Cannabis-Derived Products (https://www.nap.edu/catalog/24625/the-health-effects-of-cannabis-and-cannabinoids-the-current-state)WASHINGTON —Anew report (https:l/www.nap.edu/catalog/24625/the-health-effects-of-cannabis-and-cannabinoids-the-current-state) from the National Academies of Sciences, Engineering, and Medicine offers a rigorous review of scientific research published since 1999 about what is known about the health impacts of cannabis and cannabis-derived products —such as marijuana and active chemical compounds known as cannabinoids —ranging from their therapeutic effects to their risks for causing certain cancers, diseases, mental health disorders, and injuries. The committee that carried out the study and wrote the report considered more than 10,000 scientific abstracts to reach its nearly 100 conclusions. The committee also proposed ways to expand and improve the quality of cannabis research efforts, enhance data collection efforts to support the advancement of research, and address the current baxriers to cannabis research. "For years the landscape of marijuana use has been rapidly shifting as more and more states are legalizing cannabis for the treatment of medical conditions and recreational use," said Marie McCormick, chair of the committee; the Sumner and Esther Feldberg Professor of Maternal and Child Health, department of social and behavioral sciences, Harvard T.H.
    [Show full text]